Prokidney (PROK) Change in Acquisitions & Divestments (2023 - 2026)
Prokidney's (PROK) quarterly Change in Acquisitions & Divestments came in at $83.4 million in Q1 2026, down 1.78% year-on-year from $84.9 million in Q1 2025, and up 48.79% on a QoQ basis from $56.0 million in Q4 2025.
Prokidney (PROK) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Prokidney (PROK) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $83.4 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 1.78% year-over-year to $83.4 million in Q1 2026; TTM through Mar 2026 was $316.5 million, a 8.0% decrease from a year earlier, with the FY2025 full-year figure at $318.0 million, down 14.96% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $83.4 million, up from $56.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for PROK reached as high as $115.2 million in Q3 2024 and fell as low as $6.4 million in Q1 2023.
- Historically, Change in Acquisitions & Divestments has averaged $73.2 million across 4 years, with a median of $75.6 million in 2023.
- Across the five-year window, Change in Acquisitions & Divestments surged 1689.99% in 2024 and sank 35.83% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $75.6 million in 2023, then rose by 15.46% to $87.3 million in 2024, then plunged by 35.83% to $56.0 million in 2025, then soared by 48.79% to $83.4 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $83.4 million in Q1 2026, $56.0 million in Q4 2025, and $112.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.37 Mn |
| Mar 31, 2026 | 83.37 Mn |
| Dec 31, 2025 | 56.03 Mn |
| Dec 31, 2025 | 56.03 Mn |
| Sep 30, 2025 | 112.75 Mn |
| Sep 30, 2025 | 112.75 Mn |
| Jun 30, 2025 | 64.37 Mn |
| Jun 30, 2025 | 64.37 Mn |
| Mar 31, 2025 | 84.87 Mn |
| Mar 31, 2025 | 84.87 Mn |
| Dec 31, 2024 | 87.32 Mn |
| Dec 31, 2024 | 87.32 Mn |
| Sep 30, 2024 | 115.18 Mn |
| Sep 30, 2024 | 115.18 Mn |
| Jun 30, 2024 | 56.67 Mn |
| Jun 30, 2024 | 56.67 Mn |
| Mar 31, 2024 | 114.77 Mn |
| Mar 31, 2024 | 114.77 Mn |
| Dec 31, 2023 | 75.63 Mn |
| Dec 31, 2023 | 75.63 Mn |